Rasha M. Allam

Dr. Rasha M. Allam

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Toxicology Letters
Verified
Journal Article
Closed access
RARasha M. Allam
Rasha M. Allam
AAAhmed Al-Abd
Ahmed Al-Abd
AKAlaa M Khedr
Alaa M Khedr
OSOla A. Sharaf
Ola A. Sharaf
SNSalwa M. Nofal
Salwa M. Nofal
AAAshraf B. Abdel-Naim
Ashraf B. Abdel-Naim

1 February 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ASAbeer Salama
Abeer Salama
RARasha M. Allam
Rasha M. Allam


26 February 2024 in Bioorganic Chemistry
Verified
Journal Article
Closed access
RARasha M. Allam
Rasha M. Allam
AKAhmed M. El Kerdawy
Ahmed M. El Kerdawy
AGAhmed E. Gouda
Ahmed E. Gouda
KAKawkab A. Ahmed
Kawkab A. Ahmed
HAHeba Abdel-Mohsen
Heba Abdel-Mohsen

14 February 2024 in RSC Advances
Verified
Journal Article
Open access
PDF file
ASAhmed Sabt
Ahmed Sabt
MKMohammed Khedr
Mohammed Khedr
Wagdy Mohamed EldehnaWagdy Mohamed Eldehna
Wagdy Mohamed Eldehna
Abdelsamed ElshamyAbdelsamed Elshamy
Abdelsamed Elshamy
Mohamed Fayed abdelhameedMohamed Fayed abdelhameed
Mohamed Fayed abdelhameed
RBRasha Z. Batran
Rasha Z. Batran
New pyrazolylindolin-2-one linked coumarin derivatives were designed as dual BRAFV600E/VEGFR-2 inhibitors targeting melanoma cells A375. Docking simulation showed various interactions with the binding residues in BRAFV600E and VEGFR-2 active sites.

24 February 2020 in Journal of Heterocyclic Chemistry
Verified
Journal Article
Closed access
PDF file
Asmaa SayedAsmaa Sayed
Asmaa Sayed
MAMariam A. Azzam
Mariam A. Azzam
FMFathia Mahdy
Fathia Mahdy
SESomia El‐Maghraby
Somia El‐Maghraby
RARasha M. Allam
Rasha M. Allam